Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHF 5993 pMDI Bioavailability in Healthy Volunteers
NCT02359292Phase 1Completed
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Start
- Feb 2015
- Primary completion
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of beclomethasone dipropionate, formoterol and glycopyrronium bromide in asthma, sponsored by Chiesi Farmaceutici S.p.A. Started Feb 2015; status: completed.
02
Drugs
beclomethasone dipropionateformoterolglycopyrronium bromide
03
Conditions
asthma
Beyond the preview
Go deeper on NCT02359292.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02359292.